Optimal Stepdown therapy for Controlled pediatric Asthma Responded to SFC (OSCAR) study

Optimal Stepdown therapy for Controlled pediatric Asthma Responded to SFC (OSCAR) study - Oscar study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000004498

Enrollment

150

Registered

2010-11-03

Start date

2010-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

asthma

Interventions

SFC (100 mcrg/day) FP (200 mcrg/day)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Children with asthma whose asthmatic conditions have been stable for more than 12 weeks with SCF. Children with asthma whose P-ACT shows 25 points or more at the end of run-in period. Children with asthma whose %PEF shows 80% or more. Children with asthma in whom measuring lung function and FeNO is available.

Exclusion criteria

Exclusion criteria: Patients in whom steroid (oral/injection) has been adminstered. Patients who experienced asthma exacerbations during run-in period. Patients who did not keep diary.

Design outcomes

Primary

Measure	Time frame
Changes in predicted morning PEFR value	—

Secondary

Measure	Time frame
cahnges in lung function change in FeNO value chnages in symptom score	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026